Calcitonin Gene-Related Peptide Monoclonal Antibody Versus Botulinum Toxin for the Preventive Treatment of Chronic Migraine: Evidence From Indirect Treatment Comparison

• Main Authors: Jiajie Lu (Author), Quanquan Zhang (Author), Xiaoning Guo (Author), Wei Liu (Author), Chunyang Xu (Author), Xiaowei Hu (Author), Jianqiang Ni (Author), Haifeng Lu (Author), Hongru Zhao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The previously approved botulinum toxin and nowadays promising calcitonin gene-related peptide (CGRP) monoclonal antibody have shown efficacy for preventing chronic migraine (CM). However, there is no direct evidence for their relative effectiveness and safety. In this study, we conducte...